This topic contains a solution. Click here to go to the answer

Author Question: A behaviorist who makes reference to self-efficacy is using a phrase associated with a. Albert ... (Read 149 times)

biggirl4568

  • Hero Member
  • *****
  • Posts: 551
A behaviorist who makes reference to self-efficacy is using a phrase associated with
 
  a. Albert Bandura.
  b. B .F. Skinner.
  c. Joseph Wolpe.
  d. self-efficacy is not a term used in behavioral work.

Question 2

The Hawthorne effect refers to:
 
  a. the expectations for success that a client brings to any therapy relationship.
  b. the added value of a good therapy relationship on therapy outcomes.
  c. improvements in behavior as a result of increased attention from others.
  d. research studies that show a significant difference between the treatment and placebo control group.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ryrychapman11

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

A

Answer to Question 2

C





 

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library